These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30007261)

  • 1. Quality disclosure and the timing of insurers' adjustments: Evidence from medicare advantage.
    McCarthy IM
    J Health Econ; 2018 Sep; 61():13-26. PubMed ID: 30007261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Despite cuts, Medicare Advantage enrollment, insurers' stocks, still surging.
    Demko P
    Mod Healthc; 2014 Apr; 44(14):17-9. PubMed ID: 24804399
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare advantage loses its advantage.
    Burns J
    Manag Care; 2013 Jan; 22(1):28-31. PubMed ID: 23379012
    [No Abstract]   [Full Text] [Related]  

  • 4. Insurers' response to selection risk: Evidence from Medicare enrollment reforms.
    Decarolis F; Guglielmo A
    J Health Econ; 2017 Dec; 56():383-396. PubMed ID: 29248062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prices for Physicians' Services in Medicare Advantage and Commercial Plans.
    Pelech DM
    Med Care Res Rev; 2020 Jun; 77(3):236-248. PubMed ID: 29936886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of Physician Services Across Insurers and Effects on Quality: Early Evidence From Medicare Advantage.
    Welch WP; Sen AP; Bindman AB
    Med Care; 2019 Oct; 57(10):795-800. PubMed ID: 31415344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between Medicare Advantage contract characteristics and quality-of-care ratings: an observational analysis of Medicare Advantage star ratings.
    Xu P; Burgess JF; Cabral H; Soria-Saucedo R; Kazis LE
    Ann Intern Med; 2015 Mar; 162(5):353-8. PubMed ID: 25732277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
    Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
    Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paying more for less? Insurer competition and health plan generosity in the Medicare Advantage program.
    Pelech D
    J Health Econ; 2018 Sep; 61():77-92. PubMed ID: 30099217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider-Offered Medicare Advantage Plans: Recent Growth And Care Quality.
    Johnson G; Lyon ZM; Frakt A
    Health Aff (Millwood); 2017 Mar; 36(3):539-547. PubMed ID: 28264957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insurers' perspectives on MA value-based insurance design model.
    Khodyakov D; Buttorff C; Bouskill K; Armstrong C; Ma S; Taylor EA; Eibner C
    Am J Manag Care; 2019 Jul; 25(7):e198-e203. PubMed ID: 31318510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and spillover effects of private insurers' coverage of hepatitis C treatment.
    Moreno GA; Mulligan K; Huber C; Linthicum MT; Dreyfus D; Juday T; Marx SE; Gonzalez YS; Brookmeyer R; Lakdawalla DN
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP236-44. PubMed ID: 27266954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system.
    Boonen LH; Schut FT
    Health Econ Policy Law; 2011 Apr; 6(2):219-35. PubMed ID: 21122187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Crushing blow'. Insurers will likely see Medicare Advantage cuts.
    Zigmond J
    Mod Healthc; 2013 Feb; 43(8):8-9. PubMed ID: 23516782
    [No Abstract]   [Full Text] [Related]  

  • 16. The Cost of Medicare Advantage.
    Frakt AB
    JAMA; 2016 Jun; 315(22):2387-8. PubMed ID: 27299607
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation frustration: insurers seek time on simplified plan summaries.
    Daly R
    Mod Healthc; 2012 Feb; 42(7):17. PubMed ID: 22396984
    [No Abstract]   [Full Text] [Related]  

  • 18. Does health insurance coverage fall when nonprofit insurers become for-profits?
    Lieber EMJ
    J Health Econ; 2018 Jan; 57():75-88. PubMed ID: 29182936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dropped out or pushed out? Insurance market exit and provider market power in Medicare Advantage.
    Pelech D
    J Health Econ; 2017 Jan; 51():98-112. PubMed ID: 28126701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare program; Medicare Advantage and prescription drug benefit programs. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2011 Sep; 76(170):54600-35. PubMed ID: 21894660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.